RBB-004

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRBB-004
Drug Alias NameRBB-004
ClassificationBiologics > Protein drugs
Mechanisms of ActionApoptosis inhibitors
TargetsNot applicable
Therapy Area/IndicationsMyocardial InfarctionRetinal Artery OcclusionBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRubicon Biotechnology Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionRetinal Artery OcclusionBrain Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A